Phase IV research: Innovation in need of ethics

Journal of Medical Ethics

Volumn 34, Issue 6, 2008, Pages 415-416

  Van Thiel, Ghislaine J M W ^a   Van Delden, Johannes J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; EDITORIAL; ETHICS; FEMALE; HUMAN; MALE; PHASE 4 CLINICAL TRIAL; RESEARCH ETHICS; RESEARCH SUBJECT; STANDARD;

AGED; CLINICAL TRIALS, PHASE IV AS TOPIC; ETHICS, RESEARCH; FEMALE; HUMANS; MALE; RESEARCH SUBJECTS;

EID: 55249094155     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/jme.2007.023911     Document Type: Editorial

References (13)

1. Council of International Organizations of Medical Sciences (CIOMS). International ethical guidelines for biomedical research involving human subjects. Geneva: CIOMS, 2002:98.
2. Vlahakes GJ. The value of phase IV clinical testing. N Engl J Med 2006;354:413-15.
3. Joubert PH. Dose optimization in drug development: role of phase IV trials. Int Congr Ser 2001;1220:51-65.
4. Martin K, Bégaud B, Latry P, et al. Differences between clinical trials and postmarketing use. Br J Clin Pharmacol 2003;57:86-92.
5. van Luijn JCF, Gribnau FWJ, Leufkens HGM. Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorization. Br J Clin Pharmacol 2007;63:159-62.
6. Food and Drug Administration. Report on the performance of drug and biologics firms in conducting postmarketing commitment studies; availability. Fed Regist 2007;72:5069-70.
7. Beauchamp TL, Childress JF. Principles of biomedical ethics. 5th ed. Oxford: Oxford University Press, 2001.
8. Jansen LA. The problem with optimism in clinical trials. IRB 2006;28:13-19.
9. Centers for Medicare & Medicaid Services. National coverage determinations with data collection as a condition of coverage: coverage with evidence development. Guidance for the public, industry and CMS staff. (12 July 2006) At http://www.cms.hhs.gov/mcd/ncpc_view_document.asp?id=8 (accessed 14 Mar 2008).
10. Ross DB. The FDA and the case of Ketek. N Engl J Med 2007;356:1601-4.
11. Andersen M, Kragstrup J, Sondergaard J. How conducting a clinical trial affects physicians'guideline adherence and drug preferences. JAMA 2006;295:2759-64.
12. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-11.
13. Global Forum for Health Research (GFHR). The 10/90 Report on Health Research 2001-2002. Geneva: GFHR xv. 2002. At http://www. globalforumhealth.org/filesupld/1090_report_01-02/01_02_front_matt.pdf (accessed 14 Mar 2008).